Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.Investors Business Daily • 03/11/25
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735PRNewsWire • 03/11/25
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)Seeking Alpha • 03/11/25
Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • 02/28/25
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.The Motley Fool • 02/28/25
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo NordiskThe Motley Fool • 02/24/25
Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.Investors Business Daily • 02/06/25
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate UpdatePRNewsWire • 02/05/25